Your Local Epidemiologist β’ 646 implied HN points β’ 23 Oct 24
- Vaccines and monoclonal antibodies have been developed to protect against RSV, especially for pregnant women and infants, showing high effectiveness in reducing hospitalizations.
- Older adults are also at risk for RSV, and the vaccine is effective for those over 60, but itβs important for them to discuss options with their healthcare providers.
- Real-world data confirms that RSV protection is effective and safer than getting the disease, but many people still lack awareness about these preventive measures.